MedTrace Logo

The Danish Multicenter Randomised Study on AAI Versus DDD Pacing in Sick Sinus Syndrome

NCT00236158 · Status: TERMINATED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 1415

Last updated 2009-02-24

No results posted yet for this study

Summary

Hypothesis Treatment with rate adaptive single chamber atrial pacing (AAIR) reduces the risk of death compared with rate adaptive dual chamber pacing (DDDR) in patients with sick sinus syndrome (SSS).

Primary purpose The primary purpose of this randomised trial is to compare AAIR and DDDR pacing in patients with SSS and normal atrioventricular (AV) conduction with respect to the primary end point overall mortality.

Conditions

  • Sick Sinus Syndrome

Interventions

DEVICE

AAIR/DDDR pacemaker

Pacemaker with single lead or dual lead

Sponsors & Collaborators

  • The DANPACE Investigator Group

    lead OTHER

Principal Investigators

  • Henning R Andersen, MD, DMSc · Skejby Sygehus, Aarhus University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1999-03-31
Primary Completion
2010-07-31
Completion
2010-07-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00236158 on ClinicalTrials.gov